Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
The world's first bivalent mRNA vaccine candidate against respiratory syncytial virus, or RSV, kicked off Phase I clinical ...
Maternal RSV vaccination enhances antibody transfer to newborns, with optimal transfer efficiency observed when given at ...
The shift to a clear recommendation for vaccination goes beyond the prior guidance "just to encourage adults to talk to their ...
Image by Arek Socha from Pixabay November 12, 2024 - By Lorna Fernandes - As fall arrives, so does respiratory syncytial ...
Hosted on MSN6d
Year in Review: RSV
FDA Approvals and Expansions In May, the FDA approved the mRNA-1345 RSV vaccine (mResvia) from Moderna for people ages 60 ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.
The newest case is the fifth to bring similar allegations against Moderna in the same court, with three others, all filed Nov ...